Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,057.02 5.99 (0.57%) as of 4:30 Mon 7/1


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 110.66(B)
Last Volume: 383,195 Avg Vol: 759,306
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 192,108 255,165 311,759 469,743
Total Sell Value $188,697,290 $247,812,013 $294,950,701 $405,465,351
Total People Sold 7 14 16 18
Total Sell Transactions 18 43 67 128
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 2430
  Page 53 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gilman Alfred G Director   –       •      –    2014-11-24 4 OE $24.41 $1,438,550 D/D 40,000 40,000     -
   Stahl Neil SVP Research and Development S   •       –      –    2014-11-24 4 S $409.71 $901,523 D/D (2,200) 3,277     -
   Stahl Neil SVP Research and Development S   •       –      –    2014-11-21 4 S $415.16 $1,289,902 D/D (3,107) 5,477     -
   Stahl Neil SVP Research and Development S   •       –      –    2014-11-18 4 GD $0.00 $0 D/D 250 18,584     -
   Stahl Neil SVP Research and Development S   •       –      –    2014-11-18 4 D $406.93 $4,659,349 D/D (11,450) 18,834     -
   Stahl Neil SVP Research and Development S   •       –      –    2014-11-18 4 OE $115.29 $1,931,915 D/D 16,757 30,284     -
   Terifay Robert J SVP Commercial   •       –      –    2014-11-18 4 AS $400.45 $9,074,200 D/D (22,362) 20,029     -
   Goldberg Murray A SVP Administration & Asst Secr   •       –      –    2014-11-17 4 GD $0.00 $0 D/D 1,930 61,172     -
   Vagelos P Roy Chairman of the Board   •       •      –    2014-11-17 4 GD $0.00 $0 D/D 24,900 369,093     -
   Terifay Robert J SVP Commercial   •       –      –    2014-11-17 4 D $401.75 $10,601,379 D/D (26,388) 42,391     -
   Terifay Robert J SVP Commercial   •       –      –    2014-11-17 4 OE $21.25 $1,035,938 D/D 48,750 68,779     -
   Yancopoulos George President Regeneron Laboratori   •       •      –    2014-11-14 4 GD $0.00 $0 I/I 2,313 566,324     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2014-11-13 4 S $399.21 $3,424,336 D/D (8,575) 15,441     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2014-11-12 4 D $398.93 $4,039,166 D/D (10,125) 24,016     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2014-11-12 4 OE $21.25 $397,375 D/D 18,700 34,141     -
   Goldstein Joseph L Director   –       •      –    2014-11-12 4 S $398.31 $1,991,550 D/D (5,000) 4,000     -
   Goldstein Joseph L Director   –       •      –    2014-11-12 4 OE $177.82 $889,100 D/D 5,000 9,000     -
   Schleifer Leonard S President & CEO   •       •      –    2014-11-12 4 AS $400.22 $16,943,285 D/D (42,324) 42,087     -
   Schleifer Leonard S President & CEO   •       •      –    2014-11-11 4 AS $400.00 $1,397,200 D/D (3,493) 84,411     -
   Schleifer Leonard S President & CEO   •       •      –    2014-10-28 4 AS $400.52 $27,921,806 D/D (69,112) 91,357     -
   Schleifer Leonard S President & CEO   •       •      –    2014-10-27 4 D $402.69 $55,742,766 D/D (138,426) 160,469     -
   Schleifer Leonard S President & CEO   •       •      –    2014-10-27 4 OE $11.64 $4,982,219 D/D 256,808 292,893     -
   Goldberg Murray A SVP Administration & Asst Secr   •       –      –    2014-10-24 4 AS $395.96 $10,734,018 D/D (26,788) 63,102     -
   Brown Michael S Director   –       •      –    2014-10-24 4 AS $399.00 $1,995,000 D/D (5,000) 0     -
   Brown Michael S Director   –       •      –    2014-10-24 4 OE $57.11 $285,550 D/D 5,000 5,000     -
  2430 Records found
  Previous  50  51  52  53  54  55  56  57  58  59  Next   
  Page 53 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us